Review
Nature Reviews Immunology 9, 767-777 (November 2009) | doi:10.1038/nri2656
The follicular versus marginal zone B lymphocyte cell fate decision
Shiv Pillai1 & Annaiah Cariappa1 About the authors
Abstract
Bone marrow-derived B cells make an important cell fate choice to develop into either follicular B cells or marginal zone B cells in the spleen, which depends on signalling through the B cell receptor, Notch2, the receptor for B cell-activating factor and the canonical nuclear factor-
B pathway, as well as signals involved in the migration and anatomical retention of marginal zone B cells. Recent information discussed in this Review reconciles some of the controversies regarding the role of the B cell receptor in this cell fate decision and a clearer picture has also emerged regarding the anatomical location of ligands for Notch2 in the spleen. This cell fate decision could provide mechanistic insights that are relevant to other commitment events in lymphocytes.
- View At a Glance
Author affiliations
- Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02129, USA.
Correspondence to: Shiv Pillai1 Email: pillai@helix.mgh.harvard.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
B cells on the front lineNature Immunology News and Views (01 Jul 2000)
Should we B-leavin' now?Nature Immunology News and Views (01 Jul 2004)
See all 4 matches for News And ViewsRESEARCH
Adenomas Are Detected More Often in Morning Than in Afternoon ColonoscopyThe American Journal of Gastroenterology Article Response
See all 50 matches for Research
